Complete Filing Data
RECURSION PHARMACEUTICALS, INC. reported Stockholders Equity of $1.13 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean RECURSION PHARMACEUTICALS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $74.7M | $58.8M | $44.6M | $39.8M | $10.2M | $4.0M | $2.3M |
| Research And Development Expense | $475.3M | $314.4M | $241.2M | $155.7M | $135.3M | $63.3M | $45.8M |
| Operating Income Loss | -$648.1M | -$479.0M | -$350.1M | -$245.7M | -$182.8M | -$84.6M | -$62.4M |
| Nonoperating Income Expense | $3.2M | $14.2M | $17.9M | $6.3M | -$3.7M | -$2.4M | $562.0K |
| Net Income Loss | -$644.8M | -$463.7M | -$328.1M | -$239.5M | -$186.5M | -$87.0M | -$61.9M |
| General And Administrative Expense | $176.6M | $178.2M | $110.8M | $81.6M | $57.7M | $25.3M | $19.0M |
| Comprehensive Income Net Of Tax | -$600.4M | -$471.3M | -$328.1M | -$239.4M | -$186.6M | -$87.0M | -$61.9M |
| Cost Of Goods And Services Sold | $71.0M | $45.2M | $42.6M | $48.3M | $0.00 | $0.00 | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $44.4M | -$7.6M | $0.00 | $126.0K | -$126.0K | $0.00 | $0.00 |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $87.0K | -$162.0K | $0.00 | $0.00 | |
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax | $0.00 | $0.00 | -$39.0K | -$36.0K | $0.00 | $0.00 | |
| Tangible Asset Impairment Charges | $6.0M | $108.0K | $1.2M | $2.8M | $0.00 | $874.0K | |
| Income Tax Expense Benefit | -$136.0K | -$1.1M | -$4.1M | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$644.9M | -$464.8M | -$332.1M | -$239.5M | -$186.5M | ||
| Deferred Income Tax Liabilities Net | $23.3M | $16.6M | $1.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $5.2M | $19.2M | $14.7M | $26.1M | $14.4M | $13.8M | $10.5M | $11.0M | $12.1M | $13.2M | $7.7M | $5.3M | $2.5M | $2.5M | $2.6M | $1.0M | $186.0K | $60.0K |
| Research And Development Expense | $121.1M | $128.6M | $129.6M | $74.6M | $73.9M | $67.6M | $70.0M | $55.1M | $46.7M | $40.8M | $38.4M | $32.4M | $33.2M | $29.6M | $24.1M | $16.5M | $13.2M | $12.8M |
| Operating Income Loss | -$172.2M | -$176.2M | -$191.4M | -$98.4M | -$100.5M | -$96.3M | -$99.6M | -$81.7M | -$69.9M | -$62.6M | -$66.2M | -$56.0M | -$46.4M | -$40.9M | -$30.5M | -$22.5M | -$18.2M | -$18.3M |
| Nonoperating Income Expense | $10.0M | $4.3M | -$11.3M | $2.7M | $2.5M | $4.2M | $6.5M | $5.0M | $4.5M | $2.1M | $631.0K | $2.0K | -$1.0M | -$2.5M | -$233.0K | -$1.4M | -$726.0K | -$81.0K |
| Net Income Loss | -$162.3M | -$171.9M | -$202.5M | -$95.8M | -$97.5M | -$91.4M | -$93.0M | -$76.7M | -$65.3M | -$60.4M | -$65.6M | -$56.0M | -$47.4M | -$43.4M | -$30.7M | -$23.9M | -$18.9M | -$18.4M |
| General And Administrative Expense | $41.6M | $46.7M | $54.7M | $37.8M | $31.8M | $31.4M | $29.2M | $28.3M | $22.9M | $19.5M | $21.2M | $21.1M | $15.7M | $13.9M | $8.9M | $7.0M | $5.2M | $5.6M |
| Comprehensive Income Net Of Tax | -$171.8M | -$142.4M | -$180.7M | -$95.8M | -$97.5M | -$91.4M | -$93.0M | -$76.7M | -$65.3M | -$60.2M | -$65.4M | -$56.2M | -$47.4M | -$43.4M | -$30.7M | -$23.9M | ||
| Cost Of Goods And Services Sold | $14.7M | $20.2M | $21.8M | $12.1M | $9.2M | $11.2M | $10.9M | $9.4M | $12.4M | $15.4M | $14.2M | $7.8M | $0.00 | $0.00 | $0.00 | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$9.5M | $29.5M | $21.8M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $197.0K | $112.0K | -$183.0K | $2.0K | $0.00 | $0.00 | $0.00 | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $197.0K | $112.0K | -$222.0K | $2.0K | $0.00 | $0.00 | $0.00 | ||||||||
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$39.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Tangible Asset Impairment Charges | $6.0M | $108.0K | $1.2M | $0.00 | ||||||||||||||
| Income Tax Expense Benefit | $3.0K | $0.00 | -$158.0K | $167.0K | -$523.0K | -$779.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$162.3M | -$171.9M | -$202.6M | -$95.7M | -$98.1M | -$92.2M | -$93.0M | -$76.7M | -$65.3M | |||||||||
| Deferred Income Tax Liabilities Net | $23.3M | $23.8M | $22.4M | $168.0K | $0.00 | $528.0K | $1.9M | $4.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.13B | $1.03B | $463.4M | $485.8M | $542.9M | -$206.3M | -$124.3M | -$63.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $753.9M | $603.0M | $401.4M | $559.1M | $295.3M | $267.2M | $75.2M | $15.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $150.9M | $201.6M | -$157.7M | $263.8M | $28.2M | $192.0M | $59.5M | |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $448.3M | $201.1M | $81.2M | ||
| Retained Earnings Accumulated Deficit | -$2.08B | -$1.43B | -$967.6M | -$639.6M | -$400.1M | -$213.6M | ||
| Restricted Cash Current | $4.6M | $3.0M | $3.2M | $1.3M | $1.6M | $2.0M | ||
| Property Plant And Equipment Net | $103.9M | $141.1M | $86.5M | $88.2M | $64.7M | $26.0M | ||
| Other Assets Noncurrent | $12.8M | $8.8M | $261.0K | $0.00 | $35.0K | $650.0K | ||
| Other Assets Current | $28.6M | $38.1M | $40.2M | $15.9M | $7.5M | $2.2M | ||
| Liabilities Current | $147.7M | $187.5M | $93.2M | $100.3M | $46.7M | $23.1M | ||
| Liabilities And Stockholders Equity | $1.47B | $1.45B | $653.7M | $701.3M | $610.3M | $298.6M | ||
| Liabilities | $343.3M | $413.8M | $190.3M | $215.5M | $67.4M | $56.6M | ||
| Contract With Customer Liability Noncurrent | $114.0M | $118.8M | $51.2M | $70.3M | $6.7M | $16.7M | ||
| Contract With Customer Liability Current | $37.6M | $61.8M | $36.4M | $56.7M | $10.0M | $10.0M | ||
| Common Stock Value | $5.0K | $4.0K | $2.0K | $2.0K | $2.0K | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $743.3M | $594.4M | $391.6M | $549.9M | $285.1M | $262.1M | ||
| Assets Current | $812.8M | $714.3M | $438.1M | $569.8M | $534.7M | $266.4M | ||
| Assets | $1.47B | $1.45B | $653.7M | $701.3M | $610.3M | $298.6M | ||
| Accrued Liabilities Current | $70.2M | $81.9M | $46.6M | $32.9M | $32.3M | $10.5M | ||
| Accounts Payable Current | $18.1M | $21.6M | $4.0M | $4.6M | $2.8M | $1.1M | ||
| Other Receivables Net Current | $24.6M | $49.2M | $3.1M | $2.8M | $9.1M | $0.00 | ||
| Operating Lease Expense | $22.2M | $16.6M | $8.1M | $7.7M | $0.00 | $0.00 | ||
| Goodwill | $162.2M | $148.9M | $52.1M | $801.0K | $801.0K | $801.0K | ||
| Restricted Cash Noncurrent | $6.0M | $5.6M | $6.6M | $7.9M | $8.7M | $3.0M | ||
| Intangible Assets Net Excluding Goodwill | $309.9M | $335.9M | $36.4M | $1.3M | $1.4M | $1.7M | ||
| Operating Lease Right Of Use Asset | $45.3M | $65.9M | $33.7M | $33.3M | $32.9M | |||
| Operating Lease Liability Noncurrent | $46.6M | $67.3M | $43.4M | $44.4M | $0.00 | |||
| Repayments Of Long Term Debt | $766.0K | $90.0K | $12.8M | $77.0K | $11.2M | |||
| Operating Lease Liability Current | $12.7M | $13.8M | $6.1M | $6.0M | $0.00 | |||
| Notes Payable Current | $97.0K | $90.0K | $1.1M | |||||
| Long Term Notes Payable | $536.0K | $633.0K | $11.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.05B | $919.1M | $933.9M | $524.6M | $584.4M | $401.2M | $438.0M | $469.0M | $430.2M | $388.0M | $437.6M | $493.6M | $599.0M | $642.7M | -$233.0M | -$182.1M | -$159.4M | -$141.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $667.1M | $533.8M | $509.2M | $435.8M | $482.8M | $306.2M | $397.2M | $416.8M | $482.4M | $464.9M | $464.1M | $518.1M | $405.0M | $643.0M | $219.1M | $253.2M | $46.3M | $62.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$93.9M | -$95.3M | -$76.7M | $222.8M | -$48.0M | -$12.5M | |||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $448.3M | $437.9M | $201.1M | $201.1M | ||||||||||
| Retained Earnings Accumulated Deficit | -$1.97B | -$1.81B | -$1.63B | -$1.25B | -$1.16B | -$1.06B | -$874.6M | -$781.6M | -$704.9M | -$582.1M | -$521.6M | -$456.1M | -$335.1M | -$287.7M | -$244.3M | ||||
| Restricted Cash Current | $3.1M | $3.1M | $3.1M | $1.6M | $1.8M | $3.2M | $2.3M | $3.3M | $1.3M | $2.1M | $1.9M | $1.5M | $10.2M | $10.2M | $5.0M | ||||
| Property Plant And Equipment Net | $111.7M | $120.0M | $126.8M | $84.4M | $83.6M | $86.7M | $86.2M | $89.8M | $90.0M | $85.8M | $81.5M | $70.7M | $55.4M | $48.5M | $44.6M | ||||
| Other Assets Noncurrent | $14.7M | $9.4M | $14.8M | $360.0K | $308.0K | $254.0K | $155.0K | $110.0K | $82.0K | $0.00 | $0.00 | $36.0K | $35.0K | $68.0K | $3.1M | ||||
| Other Assets Current | $29.2M | $37.3M | $32.0M | $42.7M | $43.7M | $41.5M | $17.8M | $18.8M | $15.6M | $13.2M | $17.0M | $15.4M | $9.4M | $4.6M | $2.6M | ||||
| Liabilities Current | $155.1M | $164.0M | $142.0M | $108.9M | $86.1M | $73.9M | $94.1M | $114.0M | $92.2M | $83.0M | $96.7M | $85.7M | $42.9M | $29.5M | $26.9M | ||||
| Liabilities And Stockholders Equity | $1.40B | $1.30B | $1.31B | $726.5M | $775.9M | $557.8M | $630.8M | $666.7M | $627.4M | $611.5M | $672.5M | $734.3M | $658.6M | $698.6M | $271.9M | ||||
| Liabilities | $352.6M | $383.2M | $371.3M | $201.9M | $191.4M | $156.7M | $192.9M | $197.7M | $197.2M | $223.5M | $234.9M | $240.8M | $59.6M | $55.9M | $56.7M | ||||
| Contract With Customer Liability Noncurrent | $111.2M | $126.2M | $129.6M | $15.7M | $29.2M | $37.4M | $51.4M | $32.4M | $57.1M | $93.9M | $89.9M | $107.1M | $9.2M | $11.7M | $14.2M | ||||
| Contract With Customer Liability Current | $47.4M | $39.7M | $39.7M | $49.6M | $32.2M | $36.6M | $44.0M | $73.1M | $57.8M | $46.8M | $63.8M | $54.2M | $10.0M | $10.0M | $10.0M | ||||
| Common Stock Value | $5.0K | $4.0K | $4.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0.00 | ||||
| Cash And Cash Equivalents At Carrying Value | $659.8M | $525.1M | $500.5M | $427.6M | $474.3M | $296.3M | $387.3M | $405.9M | $473.1M | $454.6M | $453.9M | $507.9M | $394.7M | $632.7M | $214.1M | ||||
| Assets Current | $714.1M | $587.2M | $584.1M | $474.2M | $522.4M | $343.6M | $410.5M | $431.0M | $492.1M | $481.6M | $546.0M | $619.5M | $600.9M | $647.6M | $221.8M | ||||
| Assets | $1.40B | $1.30B | $1.31B | $726.5M | $775.9M | $557.8M | $630.8M | $666.7M | $627.4M | $611.5M | $672.5M | $734.3M | $658.6M | $698.6M | $271.9M | ||||
| Accrued Liabilities Current | $53.1M | $64.3M | $56.8M | $40.6M | $33.4M | $26.1M | $39.8M | $32.9M | $25.0M | $26.8M | $24.4M | $23.1M | $25.1M | $12.7M | $11.1M | ||||
| Accounts Payable Current | $13.9M | $19.3M | $25.1M | $2.3M | $3.8M | $5.1M | $4.3M | $2.1M | $4.2M | $3.9M | $3.2M | $4.2M | $6.3M | $3.2M | $3.1M | ||||
| Other Receivables Net Current | $21.9M | $21.6M | $46.1M | $2.3M | $2.5M | $2.6M | $3.2M | $3.1M | $2.1M | $11.6M | $11.7M | $11.4M | $2.2M | ||||||
| Operating Lease Expense | $6.1M | $2.5M | $2.0M | $1.7M | $1.3M | ||||||||||||||
| Goodwill | $162.0M | $164.3M | $158.1M | $52.1M | $52.1M | $52.1M | $52.8M | $60.5M | $801.0K | $801.0K | $801.0K | $801.0K | |||||||
| Restricted Cash Noncurrent | $4.2M | $5.6M | $5.6M | $6.6M | $6.6M | $6.6M | $7.6M | $7.6M | $7.9M | $8.2M | $8.3M | $8.7M | |||||||
| Intangible Assets Net Excluding Goodwill | $322.3M | $341.3M | $335.8M | $34.1M | $38.2M | $33.1M | $39.5M | $42.8M | $1.3M | $1.5M | $1.2M | $1.3M | |||||||
| Operating Lease Right Of Use Asset | $47.8M | $50.3M | $53.2M | $47.9M | $44.1M | $35.5M | $34.1M | $34.9M | $35.1M | $33.7M | $34.6M | $33.3M | |||||||
| Operating Lease Liability Noncurrent | $50.0M | $53.4M | $56.0M | $53.7M | $50.2M | $43.8M | $44.3M | $45.9M | $46.8M | $46.0M | $47.8M | $47.3M | |||||||
| Repayments Of Long Term Debt | $26.0K | $24.0K | $22.0K | $20.0K | $19.0K | ||||||||||||||
| Operating Lease Liability Current | $11.5M | $11.7M | $11.9M | $8.2M | $8.6M | $6.1M | $5.4M | $5.2M | $4.4M | $5.5M | $5.2M | $4.1M | |||||||
| Notes Payable Current | $55.0K | $41.0K | $695.0K | $676.0K | $661.0K | $95.0K | $93.0K | $92.0K | $88.0K | $3.1M | $2.1M | ||||||||
| Long Term Notes Payable | $1.1M | $1.1M | $1.1M | $1.2M | $1.2M | $561.0K | $586.0K | $610.0K | $656.0K | $9.4M | $10.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $111.2M | $81.7M | $53.5M | $27.9M | $14.8M | $4.3M | $1.4M |
| Payments To Acquire Property Plant And Equipment | $6.5M | $13.7M | $12.0M | $37.1M | $39.8M | $5.8M | $3.9M |
| Net Cash Provided By Used In Operating Activities | -$371.8M | -$359.2M | -$287.8M | -$83.5M | -$158.6M | -$45.4M | -$57.0M |
| Net Cash Provided By Used In Investing Activities | -$16.9M | $260.1M | -$10.2M | $193.2M | -$271.7M | -$8.7M | -$3.9M |
| Net Cash Provided By Used In Financing Activities | $521.5M | $304.1M | $140.1M | $154.3M | $458.5M | $246.1M | $120.4M |
| Increase Decrease In Other Operating Assets | -$32.9M | $6.1M | $7.8M | $2.0K | $5.4M | $1.1M | -$632.0K |
| Increase Decrease In Other Accrued Liabilities | -$7.4M | $5.5M | $6.7M | -$576.0K | $12.8M | $4.1M | -$798.0K |
| Increase Decrease In Contract With Customer Liability | -$36.8M | -$28.0M | -$41.1M | $110.3M | -$10.0M | $26.7M | $0.00 |
| Increase Decrease In Accrued Development Expense | -$2.3M | -$264.0K | $2.7M | $522.0K | $561.0K | $1.3M | $941.0K |
| Increase Decrease In Accounts Payable | -$2.6M | $6.4M | -$987.0K | $1.8M | $1.7M | -$185.0K | -$340.0K |
| Depreciation Depletion And Amortization | $83.7M | $36.5M | $24.4M | $11.8M | $8.4M | $3.9M | $2.5M |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 4.1M | 8.1M | 12.8M | 10.7M | 8.4M | 681.0K | 65.0K |
| Payments To Acquire Intangible Assets | $2.2M | $3.4M | $597.0K | $300.0K | $0.00 | $904.0K | $0.00 |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.0M | -$3.4M | $188.0K | -$307.0K | $0.00 | $0.00 | |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | -$277.1M | -$1.8M | $0.00 | $0.00 | $2.6M | $0.00 |
| Proceeds From Issuance Of Common Stock | $528.9M | $300.4M | $128.1M | $143.7M | $462.9M | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$9.9M | -$7.1M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $36.1M | $16.1M | $8.8M | $5.6M | $1.8M | $1.3M |
| Payments To Acquire Property Plant And Equipment | $1.8M | $6.7M | $5.2M | $4.3M | $19.4M | $684.0K |
| Net Cash Provided By Used In Operating Activities | -$132.0M | -$102.3M | -$73.3M | $77.4M | -$30.8M | -$17.8M |
| Net Cash Provided By Used In Investing Activities | -$7.3M | -$6.7M | -$5.3M | $143.3M | -$19.4M | -$684.0K |
| Net Cash Provided By Used In Financing Activities | $40.5M | $13.9M | $1.9M | $2.1M | $2.1M | $6.0M |
| Increase Decrease In Other Operating Assets | -$4.8M | $1.0M | $317.0K | $7.6M | $2.8M | $132.0K |
| Increase Decrease In Other Accrued Liabilities | -$26.6M | -$18.9M | -$9.8M | -$15.9M | -$135.0K | -$1.8M |
| Increase Decrease In Contract With Customer Liability | -$9.8M | -$13.7M | -$12.1M | $144.7M | -$2.5M | $0.00 |
| Increase Decrease In Accrued Development Expense | $599.0K | -$273.0K | $676.0K | $1.4M | -$1.2M | -$400.0K |
| Increase Decrease In Accounts Payable | $3.7M | $1.2M | -$339.0K | $1.3M | $2.1M | $625.0K |
| Depreciation Depletion And Amortization | $19.3M | $7.4M | $3.7M | $2.8M | $1.4M | $937.0K |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 1.6M | 3.1M | 1.9M | 2.1M | 2.2M | |
| Payments To Acquire Intangible Assets | $0.00 | $165.0K | $0.00 | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.8M | -$219.0K | -$2.0K | $0.00 | ||
| Payments To Acquire Businesses Net Of Cash Acquired | ||||||
| Proceeds From Issuance Of Common Stock | $41.0M | $10.9M | $0.00 | |||
| Increase Decrease In Operating Lease Liability | -$3.8M | -$2.4M | -$1.3M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 447.4M | 274.2M | 207.9M | 175.5M | 125.3M | 21.8M | 21.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 447.4M | 274.2M | 207.9M | 175.5M | 125.3M | 21.8M | 21.6M | |
| Earnings Per Share Diluted | $-1.44 | $-1.69 | $-1.58 | $-1.36 | $-1.49 | $-3.99 | $-2.87 | |
| Earnings Per Share Basic | $-1.44 | $-1.69 | $-1.58 | $-1.36 | $-1.49 | $-3.99 | $-2.87 | |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 112.1M | 75.2M | 56.4M | ||
| Common Stock Shares Outstanding | 528.2M | 396.8M | 234.3M | 191.0M | 170.3M | 22.3M | ||
| Common Stock Shares Issued | 528.2M | 396.8M | 234.3M | 191.0M | 170.3M | 22.3M | ||
| Common Stock Shares Authorized | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 188.4M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 447.0M | 417.4M | 402.8M | 282.6M | 242.2M | 236.0M | 214.3M | 201.4M | 191.6M | 173.4M | 172.2M | 170.7M | 168.5M | 138.4M | 23.0M | 21.8M | 21.7M | 21.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 447.0M | 417.4M | 402.8M | 282.6M | 242.2M | 236.0M | 214.3M | 201.4M | 191.6M | 173.4M | 172.2M | 170.7M | 168.5M | 138.4M | 23.0M | 21.8M | 21.7M | 21.6M |
| Earnings Per Share Diluted | $-0.36 | $-0.41 | $-0.50 | $-0.34 | $-0.40 | $-0.39 | $-0.43 | $-0.38 | $-0.34 | $-0.35 | $-0.38 | $-0.33 | $-0.28 | $-0.31 | $-1.33 | $-1.09 | $-0.88 | $-0.85 |
| Earnings Per Share Basic | $-0.36 | $-0.41 | $-0.50 | $-0.34 | $-0.40 | $-0.39 | $-0.43 | $-0.38 | $-0.34 | $-0.35 | $-0.38 | $-0.33 | $-0.28 | $-0.31 | $-1.33 | $-1.09 | $-0.88 | $-0.85 |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 112.1M | 110.5M | 75.2M | 75.2M | |||||||||
| Common Stock Shares Outstanding | 491.8M | 432.8M | 406.4M | 286.1M | 281.0M | 237.5M | 216.3M | 206.7M | 192.2M | 174.1M | 172.8M | 171.1M | 168.6M | 168.4M | 24.0M | |||
| Common Stock Shares Issued | 491.8M | 432.8M | 406.4M | 286.1M | 281.0M | 237.5M | 216.3M | 206.7M | 192.2M | 174.1M | 172.8M | 171.1M | 168.6M | 168.4M | 24.0M | |||
| Common Stock Shares Authorized | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 188.4M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $111.2M | $81.7M | $53.5M | $27.9M | $14.8M | $4.3M | $1.4M |
| Stock Issued During Period Value Stock Options Exercised | $4.1M | $8.3M | $12.8M | $10.6M | $6.8M | $681.0K | $65.0K |
| Costs And Expenses | $722.8M | $537.8M | $394.6M | $285.6M | $193.0M | $88.6M | |
| Other Noncash Income Expense | -$9.6M | -$16.3M | $2.6M | -$830.0K | -$4.1M | -$781.0K | $0.00 |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $439.0K | $2.4M | $591.0K | $7.7M | $1.4M | $0.00 |
| Additional Paid In Capital | $3.17B | $2.47B | $1.43B | $1.13B | $943.1M | $7.3M | |
| Stock Issued During Period Value New Issues | $528.9M | $300.5M | $128.1M | $143.7M | $462.4M | ||
| Interest Paid Net | $96.0K | $55.0K | $680.0K | $989.0K | $485.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.2M | $26.2M | $36.1M | $18.3M | $16.5M | $16.1M | $16.8M | $11.8M | $8.8M | $8.9M | $5.7M | $5.6M | $3.4M | $5.3M | $1.8M | $1.0M | $892.0K | $1.3M |
| Stock Issued During Period Value Stock Options Exercised | $1.5M | $2.8M | $732.0K | $2.8M | $2.1M | $3.0M | $4.9M | $882.0K | $1.8M | $3.8M | $1.2M | $382.0K | $823.0K | $2.2M | $211.0K | $16.0K | ||
| Costs And Expenses | $177.4M | $195.5M | $206.1M | $124.4M | $115.0M | $110.1M | $110.1M | $92.7M | $82.0M | $75.7M | $73.9M | $61.3M | $48.9M | $43.5M | $33.0M | |||
| Other Noncash Income Expense | -$4.4M | $560.0K | -$716.0K | -$402.0K | -$101.0K | -$22.0K | ||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $1.1M | $80.0K | $244.0K | $4.3M | $705.0K | $0.00 | ||||||||||||
| Additional Paid In Capital | $2.98B | $2.68B | $2.55B | $1.78B | $1.74B | $1.46B | $1.31B | $1.25B | $1.14B | $970.1M | $959.4M | $949.9M | $934.2M | $930.4M | $11.3M | |||
| Stock Issued During Period Value New Issues | $254.5M | $100.0M | $41.0M | $17.0M | $261.5M | $10.9M | $42.2M | $98.8M | $462.4M | |||||||||
| Interest Paid Net | $13.0K | $14.0K | $254.0K | $306.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.